A highly pathogenic human coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has been recently recognized in Wuhan, China, as the cause of the …

Introduction and objectives To assess the effectiveness of direct oral anticoagulants vs
vitamin K antagonists in real-life patients with atrial fibrillation. Methods A systematic review …

Introduction: During the COVID-19 outbreak, non-urgent clinic visits or cardiac interventional
procedures were postponed to a later date, and the implementation of telemedicine has …

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and its prevalence
increases with age. Few data are available about the clinical performance of direct oral …

Atrial fibrillation (AF) is the most common chronic cardiac arrhythmia with an increasing
prevalence over time mainly because of population aging. It is well established that the …

Atrial fibrillation (AF) is the most common arrhythmia, ranging from 0.1% in patients< 55
years to> 9% in octogenarian patients. One important issue is represented by the 5-fold …

Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased
risk of stroke and thromboembolic complications. A rhythm control strategy with both …

This observational study aimed to investigate the efficacy and safety of non–vitamin K
antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with malignancy. A …

This is an observational study to investigate the efficacy and safety of nonvitamin K
antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with bioprosthetic …

Background Octogenarian patients are at high risk of both ischaemic and bleeding events,
and the low body weight is considered a risk factor for major bleeding in atrial fibrillation (AF) …